What does SuRo Capital do now?
SuRo Capital Corp. was a venture BDC giving investors exposure to private businesses. Effective July 1, 2026, it became Neostellar Capital Corp. and changed its Nasdaq ticker from SSSS to NSLR. Its reporting history continued. The name-and-ticker change filing documents the transition.
Corporate identity after July 2026
Neostellar remains a Nasdaq-listed investment company focused on private, venture-backed businesses. It is a non-diversified closed-end management investment company with BDC status under the Investment Company Act of 1940 and regulated investment company tax treatment. It selects, values, and eventually exits minority positions in private or newly public growth companies.
| Identity item | Current interpretation | Why it matters |
|---|---|---|
| Legal name | Neostellar Capital Corp. since July 1, 2026 | SuRo’s portfolio and reporting history continue under the new name. |
| Listing | Nasdaq Global Select Market; NSLR replaced SSSS | Investors access a private-company portfolio through a liquid public security. |
| Regulatory structure | BDC and RIC | Asset coverage, affiliated transactions, distributions, and valuation are regulated. |
| Reporting segment | One operating segment | Analysis centers on portfolio composition, fair value, NAV, and investment results rather than product revenue. |
Why the business matters
The company bridges venture capital and public markets. Private technology leaders may remain private for years, limiting direct access. SuRo/Neostellar packages those exposures into a listed vehicle while sourcing allocations, negotiating securities, estimating fair values, managing liquidity, and realizing gains. That access proposition is both its strategic relevance and its largest risk source.
How does SuRo Capital make money?
The model is capital-gains-led. The company buys equity, fund interests, SPV interests, debt, warrants, or similar securities in growth companies. It seeks appreciation as portfolio companies raise capital, improve operations, complete transactions, or reach public markets. Interest and dividends exist but historically have not covered operating expenses, making realized and unrealized portfolio changes more important than net investment income.
Where returns come from
| Return source | FY2025 evidence | Analytical meaning |
|---|---|---|
| Interest and dividend income | Not sufficient to offset a $16.5M net investment loss | The portfolio is not designed primarily as an income-producing loan book. |
| Realized gains | $33.2M for FY2025 | Cash exits and distributions validate prior marks and fund capital returns. |
| Unrealized appreciation | $32.1M for FY2025 | Private-company valuations can dominate annual results before cash is received. |
| Dividends to shareholders | $0.50 per share declared across FY2025 | Distributions are episodic and depend on realizations, tax status, liquidity, and board decisions. |
Why “revenue” is not the primary KPI
For an operating company, revenue growth and margin usually anchor analysis. Here, Q1 2026 investment income was $0.7M while unrealized appreciation changed by $158.7M. The useful lens is NAV per share, portfolio fair value, concentration, realized proceeds, net investment loss, liquidity, and the market-price discount. The FY2025 Form 10-K is therefore closer to an investment-fund report than a conventional corporate income statement.
Which portfolio companies drive value?
The portfolio is broad by company count but concentrated by fair value. At March 31, 2026, 36 holdings had aggregate fair value of $388.5M, yet the five largest positions represented $279.8M, or 72.0%. WHOOP alone represented 38.8%. This concentration can create exceptional NAV upside when a major financing validates a holding, but it also makes the vehicle sensitive to a small number of private-company marks.
Top-five concentration defines the quarter
AI and private-technology exposure is becoming more explicit
Brand recognition alone does not establish portfolio quality. Security terms, liquidation preferences, conversion rights, SPV fees, lockups, and liquidity timing determine the economics. The Q1 2026 results package provides the clearest official snapshot of cost, fair value, and concentration.
What do the latest results show?
The freshest information is the preliminary quarter ended June 30, 2026 update; full Q2 statements were scheduled for August. Q1 2026 remains the latest complete financial period. Together, the reports show a major Q1 revaluation, continued Q2 deployment, and a lower preliminary Q2 NAV range.
The Q2 preliminary signal
Q2 investments were $0.2M in Huntress Labs, $9.5M in ClickHouse, and $15.0M in the TensorWave SPV. Exits produced $6.5M from CW Opportunity 2 LP with a $4.6M gain, $0.5M from GrabAGun with a $0.3M gain, and $5.2M from HL Digital Assets. The July 8, 2026 preliminary update also reported 37 holdings and $14.7M of liquid assets.
Q1 produced an extraordinary NAV bridge
| Q1 2026 metric | Amount | Interpretation |
|---|---|---|
| Total investment income | $0.7M | Recurring income remained small relative to operating costs. |
| Operating expenses | $4.7M | Produced a $4.0M net investment loss. |
| Net realized gain | $0.9M | Limited cash realization compared with the mark-to-market move. |
| Net unrealized appreciation | $158.7M | The dominant driver of the quarter’s increase in net assets. |
| Net increase from operations | $155.6M | Equivalent to $6.13 per basic share. |
| Ending NAV per share | $14.24 | Up from $8.09 at December 31, 2025. |
At March 31, 2026, total assets were $433.3M, investments $388.5M, cash $43.3M, liabilities $71.7M, and net assets $361.6M. The Q1 2026 Form 10-Q filing package for the underlying statements and valuation disclosures.
What strategic turning points shaped the company?
SuRo’s history is a sequence of changes in access, management structure, liquidity, and brand positioning. The consequential events changed how it sources investments, bears costs, and presents its public gateway to venture capital.
From GSV Capital to Neostellar
-
2010–2011The company formed in Maryland, completed its May 2011 IPO, and began BDC investment operations. This created the listed private-growth access model that still defines the business.
-
March 2019The company became internally managed. Employees, rather than an external adviser, ran the portfolio, making compensation and corporate overhead visible in the public company’s accounts.
-
June 2020Sutter Rock Capital changed its name to SuRo Capital, reinforcing the standalone investment-company identity after the earlier GSV Capital era.
-
2024The company added $35.0M of 6.50% convertible notes due 2029, extending capital while retaining the older 6.00% notes due December 2026.
-
2025Portfolio realizations and valuation gains produced $33.2M of realized gains and $32.1M of unrealized appreciation, while two $0.25-per-share dividends returned capital.
-
Q1 2026Financing evidence at WHOOP, OpenAI, and other holdings drove NAV to $14.24 per share and increased the top-five concentration to 72.0%.
-
April–July 2026Shareholders approved an external advisory structure linked to Magnetar; the company adopted the Neostellar name and NSLR ticker while preserving the existing portfolio’s realized gains from incentive-fee treatment.
The proposed structure was detailed in the April 7 externalization filing. Its strategic premise is that Magnetar’s institutional platform can broaden sourcing, diligence, and portfolio support more effectively than a small internally managed BDC operating alone.
What creates an advantage—and where does it compete?
The potential advantage is investment access: relationships that produce allocations in sought-after private companies, expertise in complex securities, a public permanent-capital vehicle, and patience through uncertain liquidity timelines. Magnetar may deepen that capability with broader networks and institutional infrastructure.
The moat is access plus patient listed capital
The ratings are judgments anchored in a 72.0% top-five concentration, persistent net investment losses, and private-security dominance. Access is valuable but not automatically durable: the company must win allocations without overpaying and preserve liquidity.
Competitors and substitutes pressure both sourcing and valuation
| Competitive group | Examples | Pressure on SuRo/Neostellar | Company response |
|---|---|---|---|
| Listed private-tech vehicles | Destiny Tech100 and other closed-end structures | Compete for investors seeking liquid exposure to private technology. | Differentiate through portfolio selection, NAV credibility, and exit execution. |
| Private venture funds | Traditional VC and growth-equity partnerships | Compete directly for allocations and may offer founders deeper operating networks. | Use permanent capital and Magnetar’s platform to improve access and diligence. |
| Interval and evergreen funds | Private-market funds available through wealth channels | Offer diversified private exposure with periodic liquidity. | Offer daily exchange trading, transparent filings, and a concentrated venture profile. |
| Direct public substitutes | Newly listed portfolio companies after IPO | Once a holding lists, investors can buy it directly and avoid BDC expenses. | Create value through earlier entry, security terms, and portfolio-level access. |
How strong are liquidity, leverage, and capital allocation?
The Q1 2026 revaluation strengthened the balance sheet, but Q2 deployment tightened liquidity. At March 31, cash was $43.3M, investments were $388.5M, and debt carrying value was $69.9M—about 19.3% of net assets. By June 30, liquid assets were $14.7M after $24.7M of new investments.
Debt is manageable, but the 2026 maturity is near
| Capital item | Period and amount | Research implication |
|---|---|---|
| Cash | $43.3M at March 31, 2026 | Supported commitments and operating needs before heavy Q2 deployment. |
| Liquid assets | $14.7M at June 30, 2026 | A lower buffer increases dependence on exits, financing, or the planned Magnetar investment. |
| 2025 dividends | $0.25 in July plus $0.25 in December | Capital returns followed gains but should not be treated as a fixed quarterly dividend. |
| Q2 investments | $24.7M in Q2 2026 | Management continued deploying into AI and enterprise infrastructure despite uncertain liquidity timing. |
| Magnetar commitment | $20.0M tied to externalization conditions | Could replenish capital, but form and timing depend on transaction conditions and approvals. |
The external fee structure changes future economics
The advisory agreement sets a 1.75% base fee on gross assets, a 20% income incentive above a 7% annualized hurdle with catch-up, and a 20% capital-gains incentive above a 7% non-compounded preferred return on eligible investments. Pre-existing investments are excluded. The board estimated savings of about 0.77% of average total assets versus FY2025. Terms appear in the special-meeting proxy statement.
Who owns the company and how is governance changing?
Ownership was dispersed except for Chairman and CEO Mark Klein, the only disclosed holder above 5% in the 2026 proxy. That creates insider alignment without control. A predominantly independent board and valuation committee matter because private-company marks directly determine NAV.
Insider ownership is material but not controlling
| Holder or group | Shares at April 27, 2026 | Ownership | Why it matters |
|---|---|---|---|
| Mark D. Klein | 1,676,021 | 6.56% | Meaningful economic exposure and leadership influence, but no unilateral voting control. |
| Allison Green | 189,805 | Below 1% | Aligns the chief financial officer with NAV, liquidity, and capital-allocation outcomes. |
| Directors and executive officers as a group | 2,123,731 | 8.32% | Collective insider ownership is relevant but leaves outside shareholders decisive. |
| Independent directors | Five of six board seats | Board majority | Independent committees oversee audit, valuation, compensation, and nominations. |
The 2026 annual proxy reported 25,537,612 shares outstanding at the record date, 1.7M shares beneficially owned by Klein, and 2.1M shares held by the seven directors and executive officers as a group. No dual-class voting structure was disclosed; each common share carried one vote.
Externalization introduces new incentives and conflicts
The key governance test is whether broader sourcing and better outcomes offset management fees, conflict complexity, and possible gross-asset growth. Board valuation discipline and protection of per-share NAV will be decisive.
What risks and opportunities matter most?
Private-company scarcity, concentration, long holding periods, and financing-driven revaluations can create both outsized value and severe downside. AI infrastructure and enterprise software provide opportunity, but paper appreciation must convert into cash without impairing liquidity or causing dilution.
The opportunity map
The risk map
| Risk | Current factual anchor | Financial line affected | What to monitor |
|---|---|---|---|
| Valuation reversal | $158.7M Q1 2026 unrealized appreciation | NAV and change in net assets from operations | Subsequent financing terms, comparable-company prices, and valuation committee judgments. |
| Concentration | 72.0% in five holdings; 38.8% in WHOOP | Portfolio fair value and NAV per share | Top-five share, issuer-specific milestones, and diversification of new deployments. |
| Liquidity mismatch | $14.7M liquid assets at June 30, 2026 | Cash, commitments, financing needs, and dividends | Exit proceeds, unfunded commitments, debt maturity coverage, and equity issuance. |
| Expense drag | $4.0M Q1 2026 net investment loss | NAV before portfolio gains | Base fees, incentive fees, administration expense, and recurring investment income. |
| Market-price discount | $10.71 share price versus $14.24 NAV at March 31, 2026 | Cost of equity and dilution risk | Discount to NAV, repurchases, issuance price, and investor confidence in marks. |
| External-manager conflicts | 1.75% base fee plus incentive fees on eligible assets | Operating expense and per-share NAV | Related-party allocation, gross-asset growth, leverage, and independent-board oversight. |
Official filings emphasize valuation, leverage, illiquidity, competition, regulation, and externalization execution. Lower marks can reduce NAV, widen the discount, and weaken financing flexibility simultaneously.
Why does this BDC matter for valuation, and what should readers monitor?
A conventional DCF is not the cleanest primary method because recurring operating cash flow is negative and exits are uneven. A sum-of-the-parts NAV approach is more informative: value each investment, subtract debt and liabilities, add cash, then divide by diluted shares. DCF work is more useful at portfolio-company level or for testing adviser economics.
The valuation checklist is portfolio-specific
The FY2025 results provide a useful baseline: $205.3M of net assets, $8.09 NAV per share, $225.5M of portfolio fair value, $50.1M of liquid assets, $33.2M of realized gains, $32.1M of unrealized appreciation, and a $16.5M net investment loss. The official FY2025 earnings release shows why one-year operating income is less informative than the interaction of NAV, realizations, expenses, and liquidity.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
